These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 13742239)

  • 1. A new and safer monoamine oxidase inhibitor.
    ROBIE TR
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():31-48. PubMed ID: 13742239
    [No Abstract]   [Full Text] [Related]  

  • 2. [On monoamine-oxidase inhibitors].
    KROEBER E
    Psychiatr Neurol (Basel); 1960 Jul; 140():92-6. PubMed ID: 13754442
    [No Abstract]   [Full Text] [Related]  

  • 3. [Our experiences with monoamine oxidase inhibiting substances].
    TAUBER CG
    Psychiatr Neurol (Basel); 1960 Jul; 140():148-51. PubMed ID: 13775480
    [No Abstract]   [Full Text] [Related]  

  • 4. A report on the effects of phenelzine (nardil), a monoamine oxidase inhibitor, in depressed patients.
    MIDDLEFELL R; FROST I; EGAN GP; EATON H
    J Ment Sci; 1960 Oct; 106():1533-8. PubMed ID: 13770370
    [No Abstract]   [Full Text] [Related]  

  • 5. A clinical and biochemical study of monoamine oxidase inhibition in depressed patients. I. A clinical trial of Nialamide.
    DEWHURST WG; PARE CM
    J Ment Sci; 1961 Mar; 107():239-43. PubMed ID: 13722403
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative trial of four monoamine oxidase inhibitors on chronic depressives.
    BATES TJ; DOUGLAS AD
    J Ment Sci; 1961 May; 107():538-46. PubMed ID: 13687739
    [No Abstract]   [Full Text] [Related]  

  • 7. A clinical and biochemical study of monoamine oxidase inhibition in depressed patients. II. 5-Hydroxytryptamine tolerance before and after Nialamide.
    DEWHURST WG; PARE CM
    J Ment Sci; 1961 Mar; 107():244-9. PubMed ID: 13722404
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of a monoamine oxidase inhibiting hydrazide, isocarboxazide for the treatment of mental depression].
    RISER M; GAYRAL L; HURON R; TURNIN J; CARRIE J
    Toulouse Med; 1960 Oct; 61():707-13. PubMed ID: 13741834
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of the action of the isopropylhydrazide of p-chlorophenoxyacetic acid (P.C. 603), a new monoamine oxidase inhibitor, in depressive states].
    BORENSTEIN P; DABBAH M; KRAMARZ P; HENON C
    Ann Med Psychol (Paris); 1961 Oct; 119(2)():554-65. PubMed ID: 13871268
    [No Abstract]   [Full Text] [Related]  

  • 10. Etryptamine, a new and safer antidepressant chemical.
    ROBIE TR
    Dis Nerv Syst; 1961 Aug; 22():452-6. PubMed ID: 13742241
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of geriatric patients with etryptamine acetate.
    KIESSLING AJ
    J Neuropsychiatr; 1961 Feb; 2(Suppl1)():64-5. PubMed ID: 13755873
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic re-orientation in some depressive states: clinical evaluation of a new mono-amine oxidase inhibitor (W-1554-A, phenelzine, Nardil).
    FURST W
    Am J Psychiatry; 1959 Nov; 116():429-34. PubMed ID: 13825724
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacological treatment of depressive states with a new monoamine oxidase antagonist].
    ANDERSON M
    Minerva Med; 1959 Dec; 50():4461-8. PubMed ID: 13793412
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical experiments with monoamino oxidase inhibitors on a psychiatric clientele.
    Gottfries CG
    Acta Psychiatr Scand; 1961; 36(4):539-52. PubMed ID: 13707432
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of various amine oxidase inhibitors as antidepressants.
    DUNLOP E
    Psychosomatics; 1962; 3():53-6. PubMed ID: 13888486
    [No Abstract]   [Full Text] [Related]  

  • 16. Some remarks about monoamine oxidase and monoamine oxidase inhibitors.
    ZELLER EA
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():125-30. PubMed ID: 13788170
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of iproniazid with other amine oxidase inhibitors, including W-1544, JB-516, RO 4-1018, and RO 5-0700.
    BAILEY SD; BUCCI L; GOSLINE E; KLINE NS; PARK IH; ROCHLIN D; SAUNDERS JC; VAISBERG M
    Ann N Y Acad Sci; 1959 Sep; 80():652-68. PubMed ID: 13795859
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experience in the treatment of mental depression with and inhibitor of cerebral monoamine oxidase: beta-phenyl-isopropyl hydrazine].
    CASTELLUCCIO R
    Sem Med; 1960 May; 116():867-80. PubMed ID: 13808292
    [No Abstract]   [Full Text] [Related]  

  • 19. A monoamine oxidase inhibitor in the treatment of organic disease.
    MUETHER RO; SCHUETZ A; DEL ROSARIO H; SOMMER AJ
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():80-5. PubMed ID: 13773597
    [No Abstract]   [Full Text] [Related]  

  • 20. Response of chronic schizophrenics to a monoamine oxidase inhibitor.
    GUERTIN WH; REGNIER WO; GOOD RW; NICHOLSON G
    Dis Nerv Syst; 1960 Jun; 21():330-2. PubMed ID: 13830070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.